BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15713484)

  • 1. Structure of the carboxypeptidase Y inhibitor IC in complex with the cognate proteinase reveals a novel mode of the proteinase-protein inhibitor interaction.
    Mima J; Hayashida M; Fujii T; Narita Y; Hayashi R; Ueda M; Hata Y
    J Mol Biol; 2005 Mar; 346(5):1323-34. PubMed ID: 15713484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The multiple site binding of carboxypeptidase Y inhibitor (IC) to the cognate proteinase. Implications for the biological roles of the phosphatidylethanolamine-binding protein.
    Mima J; Narita Y; Chiba H; Hayashi R
    J Biol Chem; 2003 Aug; 278(32):29792-8. PubMed ID: 12791700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of interaction site of propeptide toward mature carboxypeptidase Y (mCPY) based on the similarity between propeptide and CPY inhibitor (IC).
    Nagayama M; Kuroda K; Ueda M
    Biosci Biotechnol Biochem; 2012; 76(1):153-6. PubMed ID: 22232268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystallization and preliminary X-ray analysis of carboxypeptidase Y inhibitor IC complexed with the cognate proteinase.
    Mima J; Hayashida M; Fujii T; Hata Y; Hayashi R; Ueda M
    Acta Crystallogr D Biol Crystallogr; 2004 Sep; 60(Pt 9):1622-4. PubMed ID: 15333936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A high-affinity inhibitor of yeast carboxypeptidase Y is encoded by TFS1 and shows homology to a family of lipid binding proteins.
    Bruun AW; Svendsen I; Sørensen SO; Kielland-Brandt MC; Winther JR
    Biochemistry; 1998 Mar; 37(10):3351-7. PubMed ID: 9521655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 2.2 A crystal structure of human chymase in complex with succinyl-Ala-Ala-Pro-Phe-chloromethylketone: structural explanation for its dipeptidyl carboxypeptidase specificity.
    Pereira PJ; Wang ZM; Rubin H; Huber R; Bode W; Schechter NM; Strobl S
    J Mol Biol; 1999 Feb; 286(1):163-73. PubMed ID: 9931257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of aspartic proteinase from Irpex lacteus in complex with inhibitor pepstatin.
    Fujimoto Z; Fujii Y; Kaneko S; Kobayashi H; Mizuno H
    J Mol Biol; 2004 Aug; 341(5):1227-35. PubMed ID: 15321718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression and functional characterization of a serine carboxypeptidase inhibitor (I(C)) from Saccharomyces cerevisiae.
    Mima J; Suzuki H; Takahashi M; Hayashi R
    J Biochem; 2002 Dec; 132(6):967-73. PubMed ID: 12473200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative evaluation of each catalytic subsite of cathepsin B for inhibitory activity based on inhibitory activity-binding mode relationship of epoxysuccinyl inhibitors by X-ray crystal structure analyses of complexes.
    Watanabe D; Yamamoto A; Tomoo K; Matsumoto K; Murata M; Kitamura K; Ishida T
    J Mol Biol; 2006 Oct; 362(5):979-93. PubMed ID: 16950396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kunitz-type soybean trypsin inhibitor revisited: refined structure of its complex with porcine trypsin reveals an insight into the interaction between a homologous inhibitor from Erythrina caffra and tissue-type plasminogen activator.
    Song HK; Suh SW
    J Mol Biol; 1998 Jan; 275(2):347-63. PubMed ID: 9466914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The three-dimensional structures of tick carboxypeptidase inhibitor in complex with A/B carboxypeptidases reveal a novel double-headed binding mode.
    Arolas JL; Popowicz GM; Lorenzo J; Sommerhoff CP; Huber R; Aviles FX; Holak TA
    J Mol Biol; 2005 Jul; 350(3):489-98. PubMed ID: 15961103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two reactive site locations and structure-function study of the arrowhead proteinase inhibitors, A and B, using mutagenesis.
    Xie ZW; Luo MJ; Xu WF; Chi CW
    Biochemistry; 1997 May; 36(19):5846-52. PubMed ID: 9153425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis for the inhibition of porcine pepsin by Ascaris pepsin inhibitor-3.
    Ng KK; Petersen JF; Cherney MM; Garen C; Zalatoris JJ; Rao-Naik C; Dunn BM; Martzen MR; Peanasky RJ; James MN
    Nat Struct Biol; 2000 Aug; 7(8):653-7. PubMed ID: 10932249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of binding energy of chymostatin with human cathepsin A and its homologous proteins by molecular orbital calculation.
    Yoshida T; Lepp Z; Kadota Y; Satoh Y; Itoh K; Chuman H
    J Chem Inf Model; 2006; 46(5):2093-103. PubMed ID: 16995740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of a processing system for proteases using yeast cell surface engineering: conversion of precursor of proteinase A to active proteinase A.
    Kato M; Kuzuhara Y; Maeda H; Shiraga S; Ueda M
    Appl Microbiol Biotechnol; 2006 Oct; 72(6):1229-37. PubMed ID: 16586102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substrate specificity determinants of human macrophage elastase (MMP-12) based on the 1.1 A crystal structure.
    Lang R; Kocourek A; Braun M; Tschesche H; Huber R; Bode W; Maskos K
    J Mol Biol; 2001 Sep; 312(4):731-42. PubMed ID: 11575928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel inhibitor for prolyl tripeptidyl aminopeptidase from Porphyromonas gingivalis and details of substrate-recognition mechanism.
    Xu Y; Nakajima Y; Ito K; Zheng H; Oyama H; Heiser U; Hoffmann T; Gärtner UT; Demuth HU; Yoshimoto T
    J Mol Biol; 2008 Jan; 375(3):708-19. PubMed ID: 18042490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The three-dimensional structure at 2.4 A resolution of glycosylated proteinase A from the lysosome-like vacuole of Saccharomyces cerevisiae.
    Aguilar CF; Cronin NB; Badasso M; Dreyer T; Newman MP; Cooper JB; Hoover DJ; Wood SP; Johnson MS; Blundell TL
    J Mol Biol; 1997 Apr; 267(4):899-915. PubMed ID: 9135120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational lability in serine protease active sites: structures of hepatocyte growth factor activator (HGFA) alone and with the inhibitory domain from HGFA inhibitor-1B.
    Shia S; Stamos J; Kirchhofer D; Fan B; Wu J; Corpuz RT; Santell L; Lazarus RA; Eigenbrot C
    J Mol Biol; 2005 Mar; 346(5):1335-49. PubMed ID: 15713485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of the human carboxypeptidase N (kininase I) catalytic domain.
    Keil C; Maskos K; Than M; Hoopes JT; Huber R; Tan F; Deddish PA; Erdös EG; Skidgel RA; Bode W
    J Mol Biol; 2007 Feb; 366(2):504-16. PubMed ID: 17157876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.